NIH-funded research NIH-funded research

Functional screen of hydrocephalus and heart-disease genes in a frog model

Official title: The functional screening of congenital hydrocephalus and heart disease genes in Xenopus

Funded at Yale University · NIH-11608553 · Data updated 2026-11-12

A study uses frog embryos to test how human genetic changes might cause congenital hydrocephalus and related heart defects, with the goal of understanding why these conditions occur.

More Heart Disease research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionYale University
NIH-funded
Lab location1 site (New Haven, United States)
Project startSeptember 11, 2026
Project endAugust 31, 2027
Funding year2026
Award (this year)$499,656
NIH project number1R56HD120596-01A1
Project IDNIH-11608553 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are pediatric patients with congenital hydrocephalus and/or congenital heart disease whose genetic data reveal variants under study, or data derived from such patient populations.

Less likely to help

Patients without the specific genetic variants studied or without access to future translational follow-up may see no direct benefit.

What this research studies

Researchers at Yale will use the Xenopus frog model to functionally test genes and genetic variants found in patients with congenital hydrocephalus and heart disease. They will combine imaging with genetic screening to identify which variants drive brain ventricle enlargement and cardiac changes. This work aims to map how specific genes contribute to disease when altered, helping to clarify pathogenesis. The project builds on previous work showing OCT imaging can reveal both brain and heart phenotypes in mutant tadpoles. Findings could pave the way for targeted future therapies or diagnostic approaches.

Why it matters

Potential benefit: If successful, the work could improve understanding of why hydrocephalus and heart defects co-occur, guiding future treatments and diagnostics for affected children.

How similar studies have gone: Prior work has shown that functional screening in Xenopus can reveal disease-relevant gene effects, supporting potential translational impact though this exact combination is relatively novel.

Where this research is happening

  • Yale University
    New Haven, United States
    Active

Researchers

  • Principal investigator: Deniz, Engin — Yale University
  • Study coordinator: Deniz, Engin

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.